The S.E.C. alleged shortcomings in research said to support the drug, and its developer agreed to a $40 million settlement.

Scientists say they have achieved a "first" in the development of drugs to treat Alzheimer's disease. In a study published in the journal Alzheimer's & Dementia, a team of researchers report the ...

Leptin, a hormone that helps with weight control, also plays a role in normal cognition. Leptin resistance occurs when the ...

An international team of researchers have made a promising breakthrough in the development of drugs to treat Alzheimer’s ...

In a recent study, lean muscle mass appeared to be a protective factor against the development of Alzheimer's disease.

The research, published in Alzheimer's & Dementia: The Journal of the Alzheimer's Association, was led by Lancaster University in collaboration with the University of Southampton, Nottingham Trent ...

Researchers believe their work will have a significant impact on drug discovery efforts in the field of neurodegenerative ...

The annual Walk to End Alzheimer’s in Longview is scheduled Saturday. The event will begin at 9:30 a.m. at Teague Park, 415 ...

Professionals and caregivers alike are invited to join the Alzheimer’s Association Michigan Chapter for its Upper Peninsula Conference Monday. Registration for the event is open now. The Upper ...

Managing dementia in the complex landscape of neurological disorders stands out as a formidable challenge, affecting millions ...

SGLT2 inhibitors, a class of diabetes drugs, may reduce the risk of Alzheimer’s, vascular dementia, and Parkinson’s disease, ...